[PDF][PDF] 2018 ESC Guidelines for the diagnosis and management of syncope

M Brignole, A Moya, FJ De Lange… - Polish Heart …, 2018 - journals.viamedica.pl
Pierwsze wytyczne ESC dotyczące postępowania w omdleniach opublikowano w 2001
roku, a ich kolejne wersje w latach 2004 i 2009. W marcu 2015 roku CPG uznała, że …

New insights in diagnostics and therapies in syncope: a novel approach to non-cardiac syncope

M Brignole, G Rivasi - Heart, 2021 - heart.bmj.com
This article aims to give advice on how to identify and manage patients with syncope who
are at risk of severe outcomes, that is, at risk of trauma, potentially life-threatening episodes …

Long-term evaluation of the vagal denervation by cardioneuroablation using Holter and heart rate variability

JC Pachon-M, EI Pachon-M, CTC Pachon… - Circulation …, 2020 - Am Heart Assoc
Background: Several disorders present reflex or persistent increase in vagal tone that may
cause refractory symptoms even in a normal heart patient. Cardioneuroablation, the vagal …

[HTML][HTML] Pacing for vasovagal syncope

R Gopinathannair, BC Salgado… - Arrhythmia & …, 2018 - ncbi.nlm.nih.gov
Vasovagal syncope (VVS) is due to a common autonomic reflex involving the cardiovascular
system. It is associated with bradycardia (cardioinhibitory response) and/or hypotension …

Electroanatomic-mapping-guided cardioneuroablation versus combined approach for vasovagal syncope: a cross-sectional observational study

T Aksu, TE Guler, FO Mutluer, S Bozyel… - Journal of Interventional …, 2019 - Springer
Purpose This study was designed to assess the efficacy of electroanatomic-mapping (EAM)-
guided cardioneuroablation (CNA) vs combined approach for vasovagal syncope (VVS) …

The benefit of cardioneuroablation to reduce syncope recurrence in vasovagal syncope patients: a case-control study

T Aksu, D Padmanabhan, J Shenthar, K Yalin… - Journal of Interventional …, 2022 - Springer
Background Adequate and effective therapy for resistant vasovagal syncope patients is
lacking and the benefit of cardioneuroablation (CNA) in this cohort is still debated. The aim …

Usefulness of post-procedural heart rate response to predict syncope recurrence or positive head up tilt table testing after cardioneuroablation

T Aksu, TE Guler, S Bozyel, K Yalin… - EP …, 2020 - academic.oup.com
Aims Previous reports have suggested that cardioneuroablation (CNA) can be effective in
reducing syncopal recurrences in patients with vasovagal syncope (VVS). This study …

Catheter ablation of bradyarrhythmia: from the beginning to the future

T Aksu, TE Guler, K Yalin, FO Mutluer, KS Ozcan… - The American Journal of …, 2018 - Elsevier
Enhanced parasympathetic tone may cause sinus bradycardia or pauses, transient or
permanent atrioventricular block, with resultant vasovagal syncope. A substantial portion of …

Long‐term outcomes of cardioneuroablation with and without extra‐cardiac vagal stimulation confirmation in severe cardioinhibitory neurocardiogenic syncope

JC Pachon‐M, EI Pachon‐M… - Journal of …, 2024 - Wiley Online Library
Background Cardioneuroablation (CNA) is a novel therapeutic approach for functional
bradyarrhythmias, specifically neurocardiogenic syncope or atrial fibrillation, achieved …

Clinician needs and perceptions about cardioneuroablation for recurrent vasovagal syncope: an international clinician survey

B Vandenberk, CA Morillo, RS Sheldon, DS Chew… - Heart Rhythm, 2021 - Elsevier
Background Cardioneuroablation (CNA) targets the intrinsic cardiac autonomic nervous
system ganglionated plexi located in the peri-atrial epicardial fat. There is increasing interest …